-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JwsRhJ0FwaypiFDc+knj58ndpongE6mxLyr320hDnr9w3NQluGce+LhFCfwWWK04 KFIQNtwNpeiiiyOsGBzsjQ== 0001127602-06-002820.txt : 20061204 0001127602-06-002820.hdr.sgml : 20061204 20061204142143 ACCESSION NUMBER: 0001127602-06-002820 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061201 FILED AS OF DATE: 20061204 DATE AS OF CHANGE: 20061204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANNER DARYL K CENTRAL INDEX KEY: 0001238974 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 061253747 MAIL ADDRESS: STREET 1: OSI PHARMACEUTICALS INC STREET 2: 58 S SERVICE RD STE 110 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 form4.xml PRIMARY DOCUMENT X0202 4 2006-12-01 0000729922 OSI PHARMACEUTICALS INC OSIP 0001238974 GRANNER DARYL K C/O OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD MELVILLE NY 11747 1 Common Stock 2006-12-01 2006-12-01 4 M 0 5415 6.5 A 17360 D Common Stock 2006-12-01 2006-12-01 4 S 0 171 35.76 D 17189 D Common Stock 2006-12-01 2006-12-01 4 S 0 400 35.77 D 16789 D Common Stock 2006-12-01 2006-12-01 4 S 0 100 35.78 D 16689 D Common Stock 2006-12-01 2006-12-02 4 S 0 300 35.79 D 16389 D Common Stock 2006-12-01 2006-12-01 4 S 0 29 35.8 D 16360 D Common Stock 2006-12-01 2006-12-01 4 S 0 200 35.94 D 16160 D Common Stock 2006-12-01 2006-12-01 4 S 0 400 35.95 D 15760 D Common Stock 2006-12-01 2006-12-01 4 S 0 400 35.96 D 15360 D Common Stock 2006-12-01 2006-12-01 4 S 0 300 36.22 D 15060 D Common Stock 2006-12-01 2006-12-01 4 S 0 300 36.24 D 14760 D Common Stock 2006-12-01 2006-12-01 4 S 0 436 36.27 D 14324 D Common Stock 2006-12-01 2006-12-01 4 S 0 500 36.29 D 13824 D Common Stock 2006-12-01 2006-12-01 4 S 0 100 36.3 D 13724 D Common Stock 2006-12-01 2006-12-01 4 S 0 200 36.31 D 13524 D Common Stock 2006-12-01 2006-12-01 4 S 0 164 36.32 D 13360 D Common Stock 2006-12-01 2006-12-01 4 S 0 144 36.1 D 13216 D Common Stock 2006-12-01 2006-12-01 4 S 0 100 36.13 D 13116 D Common Stock 2006-12-01 2006-12-01 4 S 0 1171 36.17 D 11945 D Stock Option (Right to Buy) 6.5 2006-12-01 2006-12-01 4 M 0 5415 0 D 1997-03-19 2007-03-19 Common Stock 5415 0 D Transaction made pursuant to a 10b5-1 plan dated March 16, 2006. Exercisable upon the director's reelection to the Board on March 25, 1998. /s/ Michael G. Atieh, attorney-in-fact for Dr. Granner 2006-12-04 -----END PRIVACY-ENHANCED MESSAGE-----